SCHEMBL31703552

SCHEMBL31703552

Cc1nc(N2CCN(C(=O)OC(C)(C)C)CC(F)(F)C2)ccc1N

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K4 O95819 2/20 0.48
SMARCA2 P51531 1/20 0.41
SMARCA4 P51532 1/20 0.41
PBRM1 Q86U86 1/20 0.41
CKS1B P61024 2/20 0.41
SKP1 P63208 2/20 0.41
SKP2 Q13309 2/20 0.41
MAPT P10636 2/20 0.40
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
HDAC2 Q92769 2/20 0.39
PTPN11 Q06124 1/20 0.39
CYP11B2 P19099 1/20 0.38
MEN1 O00255 1/20 0.38
TSHR P16473 1/20 0.38
KMT2A Q03164 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CNR2 P34972 1/20 0.38
SUV39H2 Q9H5I1 1/20 0.37
HDAC1 Q13547 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2345673 0.86 MAP4K4 (0.61) MAP4K4SMARCA2SMARCA4PBRM1CKS1B
SCHEMBL31703634 0.84 MAPT (0.47) MAP4K4CKS1BSKP1SKP2MAPT
SCHEMBL25410640 0.81 MAP4K4 (0.47) MAP4K4SMARCA2SMARCA4PBRM1CKS1B
SCHEMBL2067686 0.76 MBOAT4 (0.34) CNR2PDE10A
SCHEMBL111508 0.76 MAP4K4 (0.66) MAP4K4SMARCA2SMARCA4PBRM1CKS1B
SCHEMBL29545935 0.76 MAP4K4 (0.66) MAP4K4SMARCA2SMARCA4PBRM1CKS1B
SCHEMBL31703650 0.75 DDB1 (0.40) MAP4K4CKS1BSKP1SKP2MAPT
SCHEMBL470891 0.75 MAP4K4 (0.56) MAP4K4CKS1BSKP1SKP2MAPT
SCHEMBL16434747 0.75 GPR119 (0.56) CKS1BSKP1SKP2MAPTALDH1A1
SCHEMBL2345124 0.74 MAP4K4 (0.66) MAP4K4HDAC2SUV39H2HDAC1GPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025215153-A1 PRMT5 INHIBITORS Ryvu Therapeutics S.A. (PL) 2025-10-16 WO disclosed